Physician profile
John B Mack
NPI 1801826151
$466.88
in general payments reported to CMS, 2019-2025
12 companies · $213 in 2025
The $213 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.16 · 2022: $99.85 · 2023: $58.96 · 2024: $20.72 · 2025: $213.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $292.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $92.36 | 2023-2025 | Progrip, Signia, Symbotex |
| Pacira Pharmaceuticals Incorporated | $73.26 | 2021-2023 | Exparel |
| Vertex Pharmaceuticals Incorporated | $72.98 | 2025 | |
| Hologic Sales and Service, LLC | $40.38 | 2023-2025 | Localizer, Trunode, Coolseal Generator |
| Solventum Corporation | $28.98 | 2025 | Activ.A.C., Prevena |
| Lexington Medical, INC. | $27.92 | 2021 | |
| Depuy Synthes Sales INC. | $27.40 | 2022 | |
| Smith+Nephew, INC. | $26.21 | 2022 | |
| Trevena, INC. | $21.92 | 2022 | |
| Davol INC. | $20.72 | 2024 | Phasix Mesh |
| Elucent Medical | $19.43 | 2025 | |
| Sanara Medtech INC. | $15.32 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.